Cell-free DNA analyses were accurate in detecting fetal antigen status as early as 10 weeks’ gestation in women with alloimmunized pregnancies, according to results of a large, diverse U.S ...

The global Cell-free fetal DNA testing market is estimated to be valued at USD 1,687.8 million in 2025 and is projected to reach USD 3,051.5 million by 2035, registering a compound annual growth rate ...

Two medical societies have responded to a recent article on cell-free fetal DNA testing in low-risk women, with mixed recommendations for clinicians. News & Perspective Drugs & Diseases ...

Non-invasive prenatal testing (NIPT), also known as prenatal-cell-free DNA-screening, allows a pregnant individual to receive a blood test that screens for very large changes in fetal chromosomes ...

Testing Fetal DNA. When Charles Cantor and Dennis Lo flew to Pattaya, Thailand in late 2002 to attend a conference, ... (CUHK), had discovered that fetal DNA makes up about 5% of the cell-free DNA in ...

A Roche blood test to screen fetuses for Down syndrome worked far better than standard prenatal screening tests in younger, low-risk women, U.S. researchers said on Wednesday, setting the stage ...

CHICAGO — A cell-free DNA blood-based test displayed 83% sensitivity for colorectal cancer detection and 90% specificity in an average-risk population, similar to the performance of current ...

Further testing, however, showed that some 2.7 percent of fetuses had chromosomal defects, including those that could not have been detected by the new fetal DNA technique.